LL37 5MG

LL-37 Peptide – Research Grade

LL-37 is a synthetic antimicrobial peptide derived from the human cathelicidin family and is widely studied in controlled laboratory environments for its role in innate immune signaling and host-defense mechanisms. This peptide is supplied exclusively for scientific and experimental research purposes and is not intended for clinical, diagnostic, or therapeutic use.

Manufactured using advanced solid-phase peptide synthesis (SPPS), LL-37 is purified to a high degree to ensure batch-to-batch consistency and analytical accuracy. Each production lot is validated using High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm molecular identity, structural integrity, and purity.

Research Characteristics

• Peptide Name: LL-37 (Cathelicidin-derived peptide)
• Synthesis Method: Solid-phase peptide synthesis (SPPS)
• Purity: ≥ 99% (HPLC verified)
• Form: Lyophilized powder
• Stability: Stable under recommended laboratory storage conditions

Experimental Applications

LL-37 is commonly utilized in in-vitro and pre-clinical research involving antimicrobial activity models, immune response signaling, inflammation-related pathways, and peptide–membrane interaction studies. Its use is strictly limited to controlled laboratory research settings where reproducibility and analytical precision are required.

Quality & Documentation

Each batch of LL-37 undergoes comprehensive quality control testing to ensure purity, consistency, and molecular accuracy prior to release.